A promising molecular pair has offered hope that could lead to the development of a new treatment to slow down Parkinson’s disease, a study by Nanyang Technological University, Singapore (NTU Singapore) and Harvard University has found.
The team led by Professor Yoon Ho Sup from the NTU School of Biological Sciences and Professor Kwang-Soo Kim from McLean Hospital and Harvard Medical School in the United States found that the ‘molecular pair’, Prostaglandin E1 (PGE1) – a type of hormone – and Prostaglandin A1 (PGA1), can be the key to boosting dopamine levels and slowing Parkinson’s disease.
Read more -> https://scienmag.com/molecular-pair-offers-potential-for-parkinsons-treatment-finds-ntu-singapore-harvard-study/